Clinical suites

SHD suite

From planning to live guidance for Structural Heart Disease procedures

    Want to learn more about SHD suite?

    Stay up-to-date and get informed about interesting topics. Or get in touch with our sales department.

    Kontaktinformation

    * Detta fält är obligatoriskt
    *

    Kontaktuppgifter

    *
    *
    *

    Företagsinformation

    *
    *
    *
    The SHD suite is a portfolio of solutions that offers you guidance during Structural Heart Disease procedures and simplified navigation for accurate device placement. It can form the core of our Hybrid OR room solution or interventional cathlab, which promotes increased confidence and flexibility for performing TAVR and other complex cardiac procedures.

    Structural Heart Diseases

     

    A paradigm shift is under way in the treatment of Structural Heart Disease. From transcatheter aortic valve replacement (TAVR) to left atrium appendage occlusions (LAAO), minimally invasive interventional procedures are on the rise. Our SHD suite aims to remove the barriers associated with these complex treatments by delivering relevant clinical value where it’s needed most – at the point of patient treatment. Driven by intuitive tools that smoothly integrate multi-modality imaging, the SHD suite enhances communication and workflow within your heart teams and helps optimize real-time navigation.

    Workflow innovation that optimizes lab performance while focusing on the patient


    Build your SHD suite on the Philips Azurion interventional X-ray system. It offers a number of workflow innovations designed to help your heart teams work efficiently and consistently, while maintaining a single-minded focus on the patient and keeping radiation dose low. In fact, the Philips Azurion platform boasts a reduction of procedure time by 17% 1(in an independently verified study for interventional radiology).

    ClarityIQ technology – clinically proven

    ClarityIQ
    In routine coronary procedures2, the system with ClarityIQ technology may reduce patient radiation dose (as total dose-area product) by 67%3 for the total procedure without affecting the procedural performance (fluoroscopy time and number of exposure images) as compared to equivalent procedures on an Allura Xper system, as demonstrated in one single-center study.4

    FlexVision Pro

    FlexVision Pro
    With FlexVision Pro, you can intuitively control all available applications at tableside via seamless mouse over to streamline your workflow. You can configure unlimited screen layouts - even during the procedure – on the high-resolution 58-inch LCD screen. This can increase efficiency and reduce the need to leave the sterile field during interventional cases.

    Touch Screen Module Pro

    Touch Screen Module Pro
    Now you can easily control the X-ray image, as well as all system settings and applications from Philips and other vendors at tableside. All without leaving the sterile field. Touch Screen Module Pro works just like a tablet for fast and easy handling.

    FlexSpot

    FlexSpot
    Gives you seamless access to all applications at one compact, customizable workplace to significantly reduce clutter and simplify workflow. Team members can perform different tasks separately, without interrupting each other, to reduce gaps between cases.

    Zero Dose Positioning

    Zero Dose Positioning
    This feature helps you manage dose by allowing you to pan the table, change table height or move the X-ray system on Last Image Hold to determine the new center position. This helps you prepare your next run without using fluoroscopy.

    Instant parallel working

    Instant parallel working
    Allows team members to work on different tasks at the same time without interrupting each other to shorten procedure times for critical heart patients. For example, while fluoroscopy/exposure is taking place, a technologist in the control room can instantly review previous images from the same patient, prepare the next exam or finish reporting on another patient.

    Clinical solutions for treating Structural Heart Diseases

    Clinical solutions for treating structural heart diseases
    Structural Heart Disease procedures depend on an accurate understanding of the anatomy and function of cardiac structures. A percutaneous left atrial appendage closure, for example, requires exceptional anatomical detail and good live visibility of vasculature for the precise sizing and placement of the device. Similarly, implanting a transcatheter aortic valve for TAVI requires careful planning based on CT imaging and live echocardiography to correctly assess the size and verify the location of the paravalvular leak. These structural heart procedures benefit from fusion imaging in addition to fluoroscopy, to guide the device to the site of the treatment.

    HeartNavigator

    Insightful planning and guidance for SHD procedures

    HearthNavigator
    Increase confidence and ease during transcatheter aortic valve replacement (TAVR) and other challenging SHD procedures. The immersive user experience is highly automated to simplify planning, device selection and projection angle selection. During procedures, HeartNavigator provides live image guidance to support device positioning.

    EchoNavigator

    Interventional tool; fusing live X-ray and live echo

    EchoNavigator
    Greater insight and confidence in finding and treating the problem through SmartFusion. EchoNavigator automatically fuses live 3D TEE and live X-ray in real time so you can intuitively guide your device in the 3D space more quickly.

    EPIQ CVxi with EchoNavigator with anatomical intelligence

    Fusing live X-ray and live echo, integrated in EPIQ

    EPIQ CVxi

    To enhance your comprehension of anatomical structures, catheters and devices location during interventional cardiac procedures, the Philips EPIQ CVxi enables multimodality decision support.

    The new integrated EchoNavigator with anatomical intelligence provides real-time fusion of live ultrasound and live X-ray images, navigation and automatic cardiac landmarks positioning with anatomical intelligence modelling.

    Disclaimers


    1. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.

    2. Routine coronary interventions comprise of fluoroscopy and exposure usage.

    3. (95% CI of 53%, 77% for all diagnostic and interventional coronary procedures). The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional cardiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task.

    4. Results based on total dose area product from a single center prospective controlled randomized study (University Hospital Gent, Belgium) on 122 patients (42 for Allura Xper and 80 for AlluraClarity) undergoing coronary procedures. Of the 122 patients, 102 (83.6%) had a diagnostic procedure without intervention and 51 (41.8%) resulted in a diagnosis of no coronary disease. Patient radiation exposure was quantified using cumulative dose area product as collected from Radiation

    Kontaktinformation

    * Detta fält är obligatoriskt
    *

    Kontaktuppgifter

    *
    *
    *

    Företagsinformation

    *
    *
    *
    *
    *

    Kommunikationsdetaljer

    Genom att specifiera anledningen till att du kontaktar oss, kan vi ge dig en bättre service
    *
    *